DOI QR코드

DOI QR Code

Development of bronchiolitis obliterans organizing pneumonia during standard treatment of hepatitis C with Peg-IFNα2b

  • Chung, Eun (Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
  • Park, Kihoon (Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
  • Kim, Jo Heon (Department of Clinical Pathology, College of Medicine, The Catholic University of Korea) ;
  • Han, Nam Ik (Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
  • Lee, Young Sok (Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
  • Bae, Si Hyun (Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
  • Park, Chung-Hwa (Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
  • Received : 2013.09.30
  • Accepted : 2013.11.18
  • Published : 2017.11.01

Abstract

Keywords

References

  1. Ghany MG, Strader DB, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009;49:1335-1374. https://doi.org/10.1002/hep.22759
  2. Dusheiko G. Side effects of alpha interferon in chronic hepatitis C. Hepatology 1997;26(3 Suppl 1):112S-121S. https://doi.org/10.1002/hep.510260720
  3. Ling VY, Mortimore M, Serisier DJ. Suspected acute exacerbation of idiopathic pulmonary fibrosis associated with interferon alpha therapy for hepatitis C: case report. Springerplus 2013;2:101. https://doi.org/10.1186/2193-1801-2-101
  4. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165:277-304. https://doi.org/10.1164/ajrccm.165.2.ats01
  5. Martins RS, Machado JA, Teixeira R. Secondary bronchiolitis obliterans organizing pneumonia during treatment of chronic hepatitis C: role of pegylated interferon alfa-2a. Rev Soc Bras Med Trop 2012;45:655-656. https://doi.org/10.1590/S0037-86822012000500023

Cited by

  1. Ropeginterferon-α-2b : Bronchiolitis obliterans organising pneumonia: case report vol.1683, pp.1, 2017, https://doi.org/10.1007/s40278-018-40541-2